ProQR Therapeutics (PRQR) Change in Acquisitions & Divestments (2018 - 2019)
ProQR Therapeutics recorded quarterly Change in Acquisitions & Divestments of -$12.2 million in Q2 2019, down 88.09% quarter-over-quarter from -$6.5 million in Q2 2018, and down 88.09% year-over-year from -$102.1 million in Q2 2018.
ProQR Therapeutics' Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at -$12.2 million for Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -12.16 Mn |
| Jun 30, 2019 | -12.16 Mn |
| Jun 30, 2018 | -6.46 Mn |
| Jun 30, 2018 | -6.46 Mn |